Unilife says exploring sale after getting ‘expression of interest’: Reuters

(Reuters) — Unilife Corp (UNIS.O), which makes injections and insulin patch pumps, said on Wednesday it had hired Morgan Stanley to help it review strategic alternatives, including a sale, after getting interest from a possible buyer.

The company received a “third-party initiated expressions of interest”, it said in a statement, without giving further details.

Unilife also said it is evaluating the possibility of a strategic partnership and licensing some of its technology.

Trading in the company’s stock was halted before U.S. markets opened.